Deerfield's latest academic investment: $100M for Harvard therapeutics

Deerfield Management announced its sixth umbrella deal with an academic partner in the past 18 months, this time committing $100 million to a subsidiary focused on developing therapeutics from Harvard University.

The new subsidiary, Lab1636, is wholly owned by Deerfield affiliates. A joint advisory committee with representation from both partners will choose discovery projects from Harvard PIs to fund through IND and potentially into the clinic. Lab1636 may provide support to launch and grow start-ups sourced from Harvard technology...